- Home
- OUST vs CMPS Comparison
OUST vs CMPS Comparison
Compare OUST & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUST
- CMPS
- Stock Information
- Founded
- OUST 2015
- CMPS 2020
- Country
- OUST United States
- CMPS United Kingdom
- Employees
- OUST N/A
- CMPS N/A
- Industry
- OUST Industrial Machinery/Components
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- OUST Technology
- CMPS Health Care
- Exchange
- OUST Nasdaq
- CMPS Nasdaq
- Market Cap
- OUST 444.3M
- CMPS 364.9M
- IPO Year
- OUST N/A
- CMPS 2020
- Fundamental
- Price
- OUST $12.23
- CMPS $4.16
- Analyst Decision
- OUST Strong Buy
- CMPS Strong Buy
- Analyst Count
- OUST 7
- CMPS 7
- Target Price
- OUST $14.24
- CMPS $18.83
- AVG Volume (30 Days)
- OUST 1.8M
- CMPS 1.0M
- Earning Date
- OUST 05-08-2025
- CMPS 05-08-2025
- Dividend Yield
- OUST N/A
- CMPS N/A
- EPS Growth
- OUST N/A
- CMPS N/A
- EPS
- OUST N/A
- CMPS N/A
- Revenue
- OUST $117,789,000.00
- CMPS N/A
- Revenue This Year
- OUST $31.39
- CMPS N/A
- Revenue Next Year
- OUST $37.34
- CMPS N/A
- P/E Ratio
- OUST N/A
- CMPS N/A
- Revenue Growth
- OUST 28.04
- CMPS N/A
- 52 Week Low
- OUST $5.84
- CMPS $2.49
- 52 Week High
- OUST $16.88
- CMPS $8.54
- Technical
- Relative Strength Index (RSI)
- OUST 69.99
- CMPS 55.37
- Support Level
- OUST $9.77
- CMPS $3.86
- Resistance Level
- OUST $10.55
- CMPS $4.52
- Average True Range (ATR)
- OUST 0.78
- CMPS 0.32
- MACD
- OUST 0.12
- CMPS -0.02
- Stochastic Oscillator
- OUST 85.42
- CMPS 32.03
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.